{
    "code": "10000790",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=10000790",
    "time": "2021-08-27 03:16:18",
    "許可證字號": "衛署菌疫輸字第000790號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "113\/02\/04",
    "發證日期": "93\/02\/04",
    "許可證種類": "菌　疫",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA01000079002",
    "中文品名": "賀癌平凍晶注射劑１５０毫克",
    "英文品名": "HERCEPTIN VIAL 150MG",
    "適應症": "Herceptin應使用於下列HER2過度表現或HER2基因amplification之早期乳癌、轉移性乳癌患者：1.早期乳癌(EBC)：(1)經外科手術、化學療法(術前或術後)之輔助療法。(2)以doxorubicin與cyclophosphamide治療，再合併pactlitaxel或docetaxel之輔助療法。(3)與docetaxel及carboplatin併用之輔助療法。(4)術前與化學療法併用和術後之輔助療法使用於治療局部晚期(包括炎症)乳癌或腫瘤(直徑>2厘米)。2.轉移性乳癌(MBC)：(1)單獨使用於曾接受過一次(含)以上化學療法之轉移性乳癌；除非患者不適合使用anthracyclin或taxane，否則先前之化學治療應至少包括anthracyclin或taxane。使用於荷爾蒙療法失敗之荷爾蒙受體陽性之患者，除非患者不適用荷爾蒙療法。(2)與pactlitaxel或docetaxel併用於未曾接受過化學療法之轉移性乳癌。(3)與芳香環酶抑制劑併用於荷爾蒙受體陽性之轉移性乳癌。3.轉移性胃癌(MGC)：Herceptin合併capecitabine(或5-fluorouracil)及cisplatin適用於未曾接受過化學治療之HER2過度表現轉移性胃腺癌(或胃食道接合處腺癌)的治療。",
    "劑型": "243凍晶注射劑",
    "包裝": "小瓶 100支以下盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "TRASTUZUMAB",
    "限制項目": "1Q不得輸入",
    "申請商名稱": "1901701100  羅氏大藥廠股份有限公司",
    "申請商地址": "台北市信義區松仁路100號40樓、40樓之1、41樓之1",
    "主製造廠": [
        {
            "製造廠名稱": "FDE0261000  ROCHE DIAGNOSTICS GMBH",
            "製造廠廠址": "SANDHOFER STRASSE 116 D-68305 MANNHEIM GERMANY",
            "製造廠公司地址": "",
            "製造廠國別": "GERMANY",
            "製程": ""
        },
        {
            "製造廠名稱": "FUS0767100  GENENTECH INC.",
            "製造廠廠址": "4625 NE BROOKWOOD PARKWAY, HILLSBORO OREGON, 97124 USA",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED STATES",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "FCH0257000  F. HOFFMANN-LA ROCHE LTD.",
            "製造廠廠址": "WURMISWEG, CH-4303 KAISERAUGST, SWITZERLAND",
            "製造廠公司地址": "",
            "製造廠國別": "SWITZERLAND",
            "製程": "二級包裝廠"
        },
        {
            "製造廠名稱": "FDE0343000  ROCHE DIAGNOSTICS GMBH",
            "製造廠廠址": "NONNENWALD 2, D-82377 PENZBERG, GERMANY",
            "製造廠公司地址": "",
            "製造廠國別": "GERMANY",
            "製程": "原料藥製造廠"
        },
        {
            "製造廠名稱": "FSG0030000  Roche Singapore Technical Operations Pte.Ltd.",
            "製造廠廠址": "10 Tuas Bay Link, 637394 Singapore",
            "製造廠公司地址": "",
            "製造廠國別": "SINGAPORE",
            "製程": "原料藥製造廠"
        }
    ],
    "CCC號列": "30049071005 抗癌藥Anti-cancer preparations",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1013000500",
            "成分名稱": "TRASTUZUMAB",
            "含量描述": "",
            "含量": "150.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "Herceptin IV_CDS21.0_0321-HER-01(450x500mm)_typesetting-110-04-19.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000790&Seq=029&Type=9"
        },
        {
            "title": "100007900003-106-05-08.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000790&Seq=003&Type=8"
        },
        {
            "title": "100007900002-106-05-08.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000790&Seq=002&Type=8"
        },
        {
            "title": "100007900001-106-05-08.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000790&Seq=001&Type=8"
        }
    ]
}